ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
6,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
6,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
8,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
9,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
